Improving Survivorship Among Minority Cancer Dyads

NCT ID: NCT04685551

Last Updated: 2022-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a result of partnership with minority social institutions (e.g. faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs). Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students. Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers. Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes. The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Breast Cancer Colon Cancer Caregiver Burnout Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Survivorship Management among African American and Latinx Cancer Dyads

This arm will implement a "one group pre-test and posttest" design to improve health outcomes of African American and Latinx cancer survivors and caregivers in collaboration with health professional students trained as Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs).

Group Type EXPERIMENTAL

Change in knowledge, motivation, skills, and resources

Intervention Type BEHAVIORAL

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Change in knowledge, motivation, skills, and resources

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals ages 18 and older
* identify as African American or Latinx
* identify as a cancer survivor and/or caregiver
* speak and/or understand English


* Individuals ages 18 and older
* identify as a healthcare provider
* provide care to cancer patients in current provider role
* speak and/or understand English


* Individuals ages 18 and older
* registered as a CDU student
* speak and/or understand English
* considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care)


* cancer survivor with a participating caregiver
* stage III or stage IV cancer diagnosis
* breast, lung, or colorectal cancer diagnosis
* identify as African American or Latinx
* speak and/or understand English

Exclusion Criteria

* individuals ages 17 years or younger
* does not identify as African American or Latinx
* unable to speak or understand English
* does not identify as a cancer survivor or caregiver

Aim 1 Focus Group for Oncology Healthcare Providers:


* individuals ages 17 years or younger
* unable to speak or understand English
* does not provide care to cancer patients
* does not identify as a healthcare provider

Aim 2:


* individuals ages 17 years or younger
* not registered as a CDU student
* unable to speak or understand English
* not considered to be underserved

For Aim 3:


* individuals ages 17 years or younger
* does not identify as African American or Latinx
* unable to speak or understand English
* does not identify as a cancer survivor
* cancer survivor does not identify a caregiver
* does not have a breast, lung, or colorectal cancer diagnosis
* not diagnosed with a stage III or stage IV cancer diagnosis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charles Drew University of Medicine and Science

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sharon Cobb

Role: PRINCIPAL_INVESTIGATOR

Charles R. Drew University of Medicine & Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charles R. Drew University of Medicine & Science

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CancerDyads

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Awareness Enhancing Interventions
NCT04683510 COMPLETED NA
Surviving Daily Life
NCT07054723 RECRUITING